Synthetic and natural iron chelators: therapeutic potential and clinical use
about
Iron chelators for acute strokeIron chelators for acute strokeNew Perspectives on the Use of Phytochemicals as an Emergent Strategy to Control Bacterial Infections Including BiofilmsParkinson's Disease: The Mitochondria-Iron LinkAntitumor Activity of 2,9-Di-Sec-Butyl-1,10-PhenanthrolineQuantitative analysis of the anti-proliferative activity of combinations of selected iron-chelating agents and clinically used anti-neoplastic drugsIron and cancer: more ore to be mined.Advances in iron chelation: an update.Intracellular Iron Chelation Modulates the Macrophage Iron Phenotype with Consequences on Tumor Progression.Biochemical and histopathological effects of green tea nanoparticles in ironized mouse model.Iron chelators with topoisomerase-inhibitory activity and their anticancer applications.Transient Proteotoxicity of Bacterial Virulence Factor Pyocyanin in Renal Tubular Epithelial Cells Induces ER-Related Vacuolation and Can Be Efficiently Modulated by Iron Chelators.Expression of Iron-Related Proteins Differentiate Non-Cancerous and Cancerous Breast Tumors.Lysosomal targeting strategies for design and delivery of bioactive for therapeutic interventions.Mechanism Governing Human Kappa-Opioid Receptor Expression under Desferrioxamine-Induced Hypoxic Mimic Condition in Neuronal NMB Cells.Cardioprotective effects of iron chelator HAPI and ROS-activated boronate prochelator BHAPI against catecholamine-induced oxidative cellular injuryStem cell-based photodynamic therapy.Anti-inflammatory effects of a novel iron chelator, DIBI, in experimental sepsis.Ethylene, an early marker of systemic inflammation in humans.Effects of Protein-Iron Complex Concentrate Supplementation on Iron Metabolism, Oxidative and Immune Status in Preweaning Calves.Restored iron transport by a small molecule promotes absorption and hemoglobinization in animals.Proteomic profiling reveals that collismycin A is an iron chelator.Iron chelation: an adjuvant therapy to target metabolism, growth and survival of murine PTEN-deficient T lymphoma and human T lymphoblastic leukemia/lymphoma.Anti-cancer iron(II) complexes of pentadentate N-donor ligands: cytotoxicity, transcriptomics analyses, and mechanisms of action.Discovery of nicoyamycin A, an inhibitor of uropathogenic Escherichia coli growth in low iron environments.Effect of the oral iron chelator deferiprone in diabetic nephropathy rats.Deferoxamine stimulates LDLR expression and LDL uptake in HepG2 cells.Iron deficiency impairs contractility of human cardiomyocytes through decreased mitochondrial function.3-Chloro-'-(2-hydroxybenzylidene) benzohydrazide: An LSD1-Selective Inhibitor and Iron-Chelating Agent for Anticancer Therapy
P2860
Q24200865-726340F3-A5DD-4A81-9D1D-B6EFA205ED8EQ24235252-720CF70D-AA45-4FEA-AD87-E37D97E1CAD6Q26741342-2F6B4068-37E0-4928-9F66-B9D7370EB5C6Q26746899-354BEFA2-6FCA-46AE-943B-38438AEAB14AQ28468510-D071610E-8593-4CB1-B6B2-9203A6218FFEQ28539989-1F2519B2-5B85-4729-8245-7D3D1C585021Q33677592-5B4504FB-1B12-4783-B11C-9BB6C30C017AQ34174307-A7F381F3-2240-4786-A36E-0049E438B878Q36180381-7B3B65CA-9F21-44A8-9DE6-888D50593436Q36374390-6875E36E-0574-42CB-BF75-E45401EB8496Q36568915-43D45FF7-3B8C-44D2-961B-96A2B1328D32Q37476514-B4822FC7-2C7F-40E0-B4C9-B2D9B284E40FQ37690976-55845D03-6E8A-4DB4-9699-543305DEFCE9Q38634529-8BD86D1A-55AE-427D-8FBF-9DFFE1A7CDC7Q38719740-1DB60155-7EF0-4DE8-877E-73A0FF198A21Q38741123-56FF40D5-1D67-4B75-8DAA-3E6862F0A087Q39352230-ED26F77F-81DD-42E9-B526-C9577E548B9EQ40068066-083E2D62-BA55-4679-AD6C-A9D6F9FE2154Q40112407-962BF36B-32C6-4C2B-9B88-B20E7BCFCD4EQ41182676-F16A4B77-9193-4688-A49A-1FA61DF3676FQ42203065-78A8226E-5452-442A-8C42-88CB65C6A925Q42358397-816606C2-2AF7-48A5-8B78-8D6A4B3A941FQ46478520-3D62C4AC-5B00-4F50-90F8-DA280A1AB7ADQ46797115-D8CB415D-46A4-4857-8E54-466A7C2D6B04Q50006927-70D31D05-98DC-42E5-9006-EF6F9F6EC396Q53113273-D59DF9C2-5ACB-475E-AB96-61D689379A0CQ53280634-AF845CB3-80B2-4E06-8E94-5222751C039FQ55259995-2413F7A5-64DD-4B72-9FD4-6760177B7EFAQ58758722-FEB26ED4-66CC-4A3A-9806-C276070B4353
P2860
Synthetic and natural iron chelators: therapeutic potential and clinical use
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Synthetic and natural iron chelators: therapeutic potential and clinical use
@en
Synthetic and natural iron chelators: therapeutic potential and clinical use.
@nl
type
label
Synthetic and natural iron chelators: therapeutic potential and clinical use
@en
Synthetic and natural iron chelators: therapeutic potential and clinical use.
@nl
prefLabel
Synthetic and natural iron chelators: therapeutic potential and clinical use
@en
Synthetic and natural iron chelators: therapeutic potential and clinical use.
@nl
P2093
P2860
P356
P1476
Synthetic and natural iron chelators: therapeutic potential and clinical use
@en
P2093
Frank M Torti
Heather C Hatcher
Ravi N Singh
Suzy V Torti
P2860
P304
P356
10.4155/FMC.09.121
P577
2009-12-01T00:00:00Z